Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?

Cells
doi 10.3390/cells8010001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Inability to Reduce Morbidity of Diarrhea by ORS: Can We Design a Better Therapy?

Pediatric Research
Child HealthPediatricsPerinatology
2018English

Nogo-A and Nogo-66 Receptor in Amyotrophic Lateral Sclerosis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2008English

Delayed Nogo Receptor Therapy Improves Recovery From Spinal Cord Contusion

Annals of Neurology
Neurology
2006English

Can We Safely Target the WNT Pathway?

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2014English

Keeping Out the Bad Guys: Gateway to Cellular Target Therapy

Cancer Research
Cancer ResearchOncology
2007English

Polo-Like-Kinase 1: A Key Cellular Target for Anti-HBV Therapy?

Hepatology
MedicineHepatology
2017English

Identification of Cellular Deoxyhypusine Synthase as a Novel Target for Antiretroviral Therapy

Journal of Clinical Investigation
Medicine
2005English

MiR-15b Can Target Insulin Receptor to Regulate Hepatic Insulin Signaling in Mice

Animal Cells and Systems
Animal ScienceZoologyGeneticsMolecular BiologyBiochemistry
2019English

The Silent Estrogen Receptor--Can We Make It Speak?

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy